Mast cell tumor classification: Difference between revisions
Jump to navigation
Jump to search
Line 18: | Line 18: | ||
:*Isolated bone marrow mastocytosis | :*Isolated bone marrow mastocytosis | ||
*Systemic mastocytosis with an associated (clonal) hematologic non–mast cell lineage disease | *Systemic mastocytosis with an associated (clonal) hematologic non–mast cell lineage disease | ||
*Aggressive systemic mastocytosis | *Aggressive systemic mastocytosis | ||
:*Lymphadenopathic systemic mastocytosis with eosinophilia | |||
*Mast cell leukemia | *Mast cell leukemia | ||
:*Aleukemic mast cell leukemia | :*Aleukemic mast cell leukemia |
Revision as of 18:53, 29 February 2016
Mast cell tumor Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Mast cell tumor classification On the Web |
American Roentgen Ray Society Images of Mast cell tumor classification |
Risk calculators and risk factors for Mast cell tumor classification |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Suveenkrishna Pothuru, M.B,B.S. [2]
Overview
Classification
Based on the affected organ(s), mast cell tumor may be classified into three subtypes:
- Cutaneous mastocytosis
- Systemic mastocytosis
- Localized mastocytosis
Mast cell tumor may be classified according to WHO classification into seven subtypes:[1]
- Cutaneous mastocytosis
- Urticaria pigmentosa
- Maculopapular cutaneous mastocytosis
- Diffuse cutaneous mastocytosis
- Mastocytoma of skin
- Indolent systemic mastocytosis
- Smoldering systemic mastocytosis
- Isolated bone marrow mastocytosis
- Systemic mastocytosis with an associated (clonal) hematologic non–mast cell lineage disease
- Aggressive systemic mastocytosis
- Lymphadenopathic systemic mastocytosis with eosinophilia
- Mast cell leukemia
- Aleukemic mast cell leukemia
- Mast cell sarcoma
- Extracutaneous mastocytoma
References
- ↑ Patnaik MM, Rindos M, Kouides PA, Tefferi A, Pardanani A (2007). "Systemic mastocytosis: a concise clinical and laboratory review". Arch Pathol Lab Med. 131 (5): 784–91. doi:10.1043/1543-2165(2007)131[784:SMACCA]2.0.CO;2. PMID 17488167.